{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:18:39Z","timestamp":1783473519823,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T00:00:00Z","timestamp":1389225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40257-013-0059-z","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T08:00:19Z","timestamp":1389168019000},"page":"1-6","source":"Crossref","is-referenced-by-count":42,"title":["Treatment of Hereditary Epidermolysis Bullosa: Updates and Future Prospects"],"prefix":"10.1007","volume":"15","author":[{"given":"Chao-Kai","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Yu-Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,9]]},"reference":[{"key":"59_CR1","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/jid.2013.127","volume":"133","author":"L Bruckner-Tuderman","year":"2013","unstructured":"Bruckner-Tuderman L, McGrath JA, Robinson EC, et al. Progress in Epidermolysis Bullosa Research: Summary of DEBRA International Research Conference 2012. J Invest Dermatol. 2013;133:2121\u20136.","journal-title":"J Invest Dermatol"},{"key":"59_CR2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","volume":"58","author":"JD Fine","year":"2008","unstructured":"Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol. 2008;58:931\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"59_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","volume":"61","author":"JD Fine","year":"2009","unstructured":"Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61:387\u2013402.","journal-title":"J Am Acad Dermatol"},{"key":"59_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","volume":"61","author":"JD Fine","year":"2009","unstructured":"Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367\u201384.","journal-title":"J Am Acad Dermatol"},{"key":"59_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jmg.2006.045302","volume":"44","author":"R Varki","year":"2007","unstructured":"Varki R, Sadowski S, Uitto J, et al. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet. 2007;44:181\u201392.","journal-title":"J Med Genet"},{"key":"59_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/1523-1747.ep12471830","volume":"100","author":"JA McGrath","year":"1993","unstructured":"McGrath JA, Ishida-Yamamoto A, O\u2019Grady A, et al. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol. 1993;100:366\u201372.","journal-title":"J Invest Dermatol"},{"key":"59_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","volume":"28","author":"HJ Chung","year":"2010","unstructured":"Chung HJ, Uitto J. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin. 2010;28:93\u2013105.","journal-title":"Dermatol Clin"},{"key":"59_CR8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"F Mavilio","year":"2006","unstructured":"Mavilio F, Pellegrini G, Ferrari S, et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med. 2006;12:1397\u2013402.","journal-title":"Nat Med"},{"key":"59_CR9","unstructured":"U.S. National Institutes of Health. Gene transfer for recessive dystrophic epidermolysis bullosa. http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01263379?term=NCT01263379&rank=1 . Accessed Oct 2013."},{"key":"59_CR10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, et al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2010;11:636\u201346.","journal-title":"Nat Rev Genet"},{"key":"59_CR11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1534\/genetics.111.131433","volume":"188","author":"D Carroll","year":"2011","unstructured":"Carroll D. Genome engineering with zinc-finger nucleases. Genetics. 2011;188:773\u201382.","journal-title":"Genetics."},{"key":"59_CR12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","volume":"21","author":"MJ Osborn","year":"2013","unstructured":"Osborn MJ, Starker CG, McElroy AN, et al. TALEN-based gene correction for epidermolysis bullosa. Mol Ther. 2013;21:1151\u20139.","journal-title":"Mol Ther"},{"key":"59_CR13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm1063","volume":"10","author":"DT Woodley","year":"2004","unstructured":"Woodley DT, Keene DR, Atha T, et al. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat Med. 2004;10:693\u20135.","journal-title":"Nat Med"},{"key":"59_CR14","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","volume":"133","author":"DT Woodley","year":"2013","unstructured":"Woodley DT, Wang X, Amir M, et al. Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa. J Invest Dermatol. 2013;133:1910\u20133.","journal-title":"J Invest Dermatol"},{"key":"59_CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1523-1747.2000.00031-5.x","volume":"115","author":"X Palazzi","year":"2000","unstructured":"Palazzi X, Marchal T, Chabanne L, et al. Inherited dystrophic epidermolysis bullosa in inbred dogs: a spontaneous animal model for somatic gene therapy. J Invest Dermatol. 2000;115:135\u20137.","journal-title":"J Invest Dermatol"},{"key":"59_CR16","unstructured":"Cogan J, Wang XY, Hou YP, Khilili M, Woodley DT, Chen M. Epitope mapping of anti-type VII collagen antibodies in the patients with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2013;133:S45."},{"key":"59_CR17","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","volume":"128","author":"T Wong","year":"2008","unstructured":"Wong T, Gammon L, Liu L, et al. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2008;128:2179\u201389.","journal-title":"J Invest Dermatol"},{"key":"59_CR18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2011.85","volume":"131","author":"N Nagy","year":"2011","unstructured":"Nagy N, Almaani N, Tanaka A, et al. HB-EGF induces COL7A1 expression in keratinocytes and fibroblasts: possible mechanism underlying allogeneic fibroblast therapy in recessive dystrophic epidermolysis Bullosa. J Invest Dermatol. 2011;131:1771\u20134.","journal-title":"J Invest Dermatol"},{"key":"59_CR19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","volume":"17","author":"JS Kern","year":"2009","unstructured":"Kern JS, Loeckermann S, Fritsch A, et al. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity. Mol Ther. 2009;17:1605\u201315.","journal-title":"Mol Ther"},{"key":"59_CR20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","volume":"118","author":"A Fritsch","year":"2008","unstructured":"Fritsch A, Loeckermann S, Kern JS, et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest. 2008;118:1669\u201379.","journal-title":"J Clin Invest"},{"key":"59_CR21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","volume":"69","author":"SS Venugopal","year":"2013","unstructured":"Venugopal SS, Yan W, Frew JW, et al. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol. 2013;69:898\u2013908.","journal-title":"J Am Acad Dermatol"},{"key":"59_CR22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","volume":"169","author":"G Petrof","year":"2013","unstructured":"Petrof G, Martinez-Quiepo M, Mellerio JE, et al. Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomised, vehicle-controlled trial. Br J Dermatol. 2013;169:1025\u201333.","journal-title":"Br J Dermatol"},{"key":"59_CR23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"P Conget","year":"2010","unstructured":"Conget P, Rodriguez F, Kramer S, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy. 2010;12:429\u201331.","journal-title":"Cytotherapy"},{"key":"59_CR24","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","volume":"108","author":"K Tamai","year":"2011","unstructured":"Tamai K, Yamazaki T, Chino T, et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci U\u00a0S\u00a0A. 2011;108:6609\u201314.","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"59_CR25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"JE Wagner","year":"2010","unstructured":"Wagner JE, Ishida-Yamamoto A, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med. 2010;363:629\u201339.","journal-title":"N Engl J Med"},{"key":"59_CR26","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/jid.2010.64","volume":"130","author":"N Almaani","year":"2010","unstructured":"Almaani N, Nagy N, Liu L, Dopping-Hepenstal PJ, et al. Revertant mosaicism in recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2010;130:1937\u201340.","journal-title":"J Invest Dermatol"},{"key":"59_CR27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81894-2","volume":"88","author":"MF Jonkman","year":"1997","unstructured":"Jonkman MF, Scheffer H, Stulp R, et al. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell. 1997;88:543\u201351.","journal-title":"Cell"},{"key":"59_CR28","first-page":"73","volume":"148","author":"JE Lai-Cheong","year":"2013","unstructured":"Lai-Cheong JE, McGrath JA. Revertant mosaicism in the skin. G Ital Dermatol Venereol. 2013;148:73\u201382.","journal-title":"G Ital Dermatol Venereol"},{"key":"59_CR29","first-page":"167","volume":"14","author":"AMG Pasmooij","year":"2012","unstructured":"Pasmooij AMG, Jonkman MF, Uitto J. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy. Discov Med. 2012;14:167\u201379.","journal-title":"Discov Med"},{"key":"59_CR30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/jid.2011.477","volume":"132","author":"AM Pasmooij","year":"2012","unstructured":"Pasmooij AM, Nijenhuis M, Brander R, et al. Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol. 2012;132:1374\u201383.","journal-title":"J Invest Dermatol"},{"key":"59_CR31","doi-asserted-by":"crossref","unstructured":"Gosty\u0144ski A, Llames S, Garc\u00eda M, et al. Long-term survival of type XVII collagen revertant cells in an animal model of revertant cell therapy. J Invest Dermatol. 2013. doi: 10.1038\/jid.2013.308","DOI":"10.1038\/jid.2013.308"},{"key":"59_CR32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2009.09118.x","volume":"161","author":"A Gostynski","year":"2009","unstructured":"Gostynski A, Deviaene FC, Pasmooij AM, et al. Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol. 2009;161:444\u20137.","journal-title":"Br J Dermatol"},{"key":"59_CR33","first-page":"S132","volume":"133","author":"A Gostynski","year":"2013","unstructured":"Gostynski A, Bremer J, Huizinga J, et al. Successful therapeutic transplantation of revertant skin in a patient with epidermolysis bullosa. J Invest Dermatol. 2013;133:S132.","journal-title":"J Invest Dermatol"},{"key":"59_CR34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"59_CR35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","volume":"131","author":"J Tolar","year":"2011","unstructured":"Tolar J, Xia L, Riddle MJ, Lees CJ, et al. Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol. 2011;131:848\u201356.","journal-title":"J Invest Dermatol"},{"key":"59_CR36","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","volume":"108","author":"M Itoh","year":"2011","unstructured":"Itoh M, Kiuru M, Cairo MS, et al. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U\u00a0S\u00a0A. 2011;108:8797\u2013802.","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"59_CR37","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1038\/jid.2013.106","volume":"133","author":"N Umegaki","year":"2013","unstructured":"Umegaki N, Guo Z, Itoh M, et al. Generation of induced pluripotent stem cells from revertant mosaic keratinocytes: a novel strategy for natural gene therapy for epidermolysis bullosa. J Invest Dermatol. 2013;133:S243\u20136.","journal-title":"J Invest Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0059-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-013-0059-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0059-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:28:32Z","timestamp":1559489312000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-013-0059-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["59"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0059-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718232777.793548153","asserted-by":"object"}]},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,9]]}}}